sibutramine has been researched along with Adenohypophyseal Hyposecretion in 2 studies
sibutramine: serotonin and norepinephrine transporter inhibitor; Meridia is tradename for sibutramine hydrochloride
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arango, C | 1 |
| Rojas, MJ | 1 |
| Moreno, D | 1 |
| Parellada, M | 1 |
| Mersebach, H | 1 |
| Klose, M | 1 |
| Svendsen, OL | 1 |
| Astrup, A | 1 |
| Feldt-Rasmussen, U | 1 |
2 other studies available for sibutramine and Adenohypophyseal Hyposecretion
| Article | Year |
|---|---|
Sibutramine for compulsive eating in hypothalamic deficiency.
Topics: Adolescent; Appetite Depressants; Cyclobutanes; Humans; Hyperphagia; Hypopituitarism; Male | 2002 |
Combined dietary and pharmacological weight management in obese hypopituitary patients.
Topics: Adult; Anthropometry; Appetite Depressants; Blood Glucose; Body Composition; Cholesterol; Combined M | 2004 |